期刊论文详细信息
Stem Cell Research & Therapy
Prospective cohort study of the circadian rhythm pattern in allogeneic sibling donors undergoing standard granulocyte colony-stimulating factor mobilization
Paul S Frenette3  Lorraine K Miller1  James H Godbold2  Erin L Moshier2  Janice L Gabrilove1  Luis M Isola1  Patricia A Shi1 
[1] Tisch Cancer Institute, Mount Sinai School of Medicine, 1190 5th Avenue, New York, NY, 10029, USA;Department of Preventive Medicine, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, New York, NY, 10029, USA;Ruth L. and David S. Gottesman Institute for Stem Cell Biology and Regenerative Medicine, Albert Einstein College of Medicine, 1301 Morris Park Avenue, Bronx, NY, 10461, USA
关键词: Hematopoietic stem cell mobilization;    Hematopoietic progenitor cells;    Granulocyte-colony stimulating factor;    Circadian rhythm;    CD38;    Antigens;    CD34;    Antigens;   
Others  :  1179376
DOI  :  10.1186/scrt180
 received in 2012-11-20, accepted in 2013-03-12,  发布年份 2013
PDF
【 摘 要 】

Introduction

Prior in vivo murine studies suggest circadian oscillations for hematopoietic stem cell release, which are maintained following administration of granulocyte colony-stimulating factor (G-CSF) or plerixafor. Furthermore, retrospective data analysis of healthy donors who underwent G-CSF-induced mobilization demonstrated significantly increased CD34+ cell yields when collected in the afternoon compared with the morning.

Methods

A prospective study was conducted to directly examine the number of peripheral blood CD34+ and CD34+CD38 progenitor/stem cells at baseline and then every 6 hours for 24 hours on days 4 to 5 of G-CSF (10 μg/kg/day in the morning) mobilization in 11 allogeneic donors. Data were analyzed using mixed-model analysis of repeated measures.

Results

Whereas we observed a significant increase in CD34+ cell counts toward the evening, counts were then sustained on the morning of day 5. The correlation between CD34+CD38 cell counts and the less defined CD34+ populations was weak.

Conclusions

Our results suggest that the pharmacodynamic activity and timing of G-CSF may alter endogenous progenitor rhythms. Donor age, medical history, and medications may also impact circadian rhythm. Further studies should examine the circadian rhythm at the peak of G-CSF mobilization and should consider potential confounders such as the time of G-CSF administration and the age of the subjects.

【 授权许可】

   
2013 Shi et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150511103705114.pdf 383KB PDF download
Figure 3. 51KB Image download
Figure 2. 63KB Image download
Figure 1. 15KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】
  • [1]Kroger N, Zander AR: Dose and schedule effect of G-GSF for stem cell mobilization in healthy donors for allogeneic transplantation. Leuk Lymphoma 2002, 43:1391-1394.
  • [2]Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson MD, Kurian S, Klein JP, Horowitz MM, Confer DL: Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood 2009, 113:3604-3611.
  • [3]Collins NH, Gee AP, Durett AG, Kan F, Zhang MJ, Champlin RE, Confer D, Eapen M, Howard A, King R, Laughlin MJ, Plante RJ, Setterholm M, Spellman S, Keever-Taylor C, Wagner JE, Weisdorf DJ: The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes. Biol Blood Marrow Transplant 2010, 16:253-262.
  • [4]Pulsipher MA, Chitphakdithai P, Logan BR, Leitman SF, Anderlini P, Klein JP, Horowitz MM, Miller JP, King RJ, Confer DL: Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose. Blood 2009, 114:2606-2616.
  • [5]Anderlini P, Donato M, Chan KW, Huh YO, Gee AP, Lauppe MJ, Champlin RE, Korbling M: Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience. Transfusion 1999, 39:555-560.
  • [6]Kroschinsky F, Holig K, Poppe-Thiede K, Zimmer K, Ordemann R, Blechschmidt M, Oelschlaegel U, Bornhauser M, Rall G, Rutt C, Ehninger G: Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors. Haematologica 2005, 90:1665-1671.
  • [7]Abrahamsen JF, Smaaland R, Sothern RB, Laerum OD: Variation in cell yield and proliferative activity of positive selected human CD34+ bone marrow cells along the circadian time scale. Eur J Haematol 1998, 60:7-15.
  • [8]Mendez-Ferrer S, Lucas D, Battista M, Frenette PS: Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008, 452:442-447.
  • [9]Lucas D, Battista M, Shi PA, Isola L, Frenette PS: Mobilized hematopoietic stem cell yield depends on species-specific circadian timing. Cell Stem Cell 2008, 3:364-366.
  • [10]Verma DS, Fisher R, Spitzer G, Zander AR, McCredie KB, Dicke KA: Diurnal changes in circulating myeloid progenitor cells in man. Am J Hematol 1980, 9:185-192.
  • [11]Kamel AM, El-Sharkawy N, Mahmoud HK, Khalaf MR, El Haddad A, Fahmy O, El Fattah RA, Sayed D: Impact of CD34 subsets on engraftment kinetics in allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2005, 35:129-136.
  • [12]Pastore D, Mestice A, Perrone T, Gaudio F, Delia M, Albano F, Russo Rossi A, Carluiccio P, Leo M, Liso V, Specchia G: Subsets of CD34+ and early engraftment kinetics in allogeneic peripheral SCT for AML. Bone Marrow Transplant 2008, 41:977-981.
  • [13]Specchia G, Pastore D, Mestice A, Liso A, Carluccio P, Leo M, Casanova M, Sibilla S, Giannoccaro M, Liso V: Early and long-term engraftment after autologous peripheral stem cell transplantation in acute myeloid leukemia patients. Acta Haematol 2006, 116:229-237.
  • [14]Henon P, Sovalat H, Becker M, Arkam Y, Ojeda-Uribe M, Raidot JP, Husseini F, Wunder E, Bourderont D, Audhuy B: Primordial role of CD34+ 38– cells in early and late trilineage haemopoietic engraftment after autologous blood cell transplantation. Br J Haematol 1998, 103:568-581.
  • [15]Cobaleda C, Gutierrez-Cianca N, Perez-Losada J, Flores T, Garcia-Sanz R, Gonzalez M, Sanchez-Garcia I: A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia. Blood 2000, 95:1007-1013.
  • [16]Gerber JM, Smith BD, Ngwang B, Zhang H, Vala MS, Morsberger L, Galkin S, Collector MI, Perkins B, Levis MJ, Griffin CA, Sharkis SJ, Borowitz MJ, Karp JE, Jones RJ: A clinically relevant population of leukemic CD34(+)CD38(−) cells in acute myeloid leukemia. Blood 2012, 119:3571-3577.
  • [17]Stroncek DF, Clay ME, Petzoldt ML, Smith J, Jaszcz W, Oldham FB, McCullough J: Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 1996, 36:601-610.
  • [18]Anderlini P, Przepiorka D, Huh Y, Lauppe J, Miller P, Sundberg J, Seong D, Champlin R, Korbling M: Duration of filgrastim mobilization and apheresis yield of CD34+ progenitor cells and lymphoid subsets in normal donors for allogeneic transplantation. Br J Haematol 1996, 93:940-942.
  • [19]Stroncek DF, Clay ME, Herr G, Smith J, Jaszcz WB, Ilstrup S, McCullough J: The kinetics of G-CSF mobilization of CD34+ cells in healthy people. Transfus Med 1997, 7:19-24.
  • [20]Bjarnason G, Reis M, Robinson JB: Circadian variation in CD34+ count and response to G-CSF therapy in healthy volunteers: implications for harvesting efficiacy. Blood 1996, 10:395a.
  • [21]Kroger N, Sonnenberg S, Cortes-Dericks L, Freiberger P, Mollnau H, Zander AR: Kinetics of G-CSF and CD34+ cell mobilization after once or twice daily stimulation with rHu granulocyte-stimulating factor (lenograstim) in healthy volunteers: an intraindividual crossover study. Transfusion 2004, 44:104-110.
  • [22]Richa E, Papari M, Allen J, Martinez G, Wickrema A, Anastasi J, Van Besien K, Artz A: Older age but not donor health impairs allogeneic granulocyte colony-stimulating factor (G-CSF) peripheral blood stem cell mobilization. Biol Blood Marrow Transplant 2009, 15:1394-1399.
  • [23]Ferraro F, Lymperi S, Mendez-Ferrer S, Saez B, Spencer JA, Yeap BY, Masselli E, Graiani G, Prezioso L, Rizzini EL, Mangoni M, Rizzoli V, Sykes SM, Lin CP, Frenette PS, Quaini F, Scadden DT: Diabetes impairs hematopoietic stem cell mobilization by altering niche function. Sci Transl Med 2011, 3:104ra101.
  • [24]Mendez-Ferrer S, Battista M, Frenette PS: Cooperation of beta(2)- and beta(3)-adrenergic receptors in hematopoietic progenitor cell mobilization. Ann N Y Acad Sci 2010, 1192:139-144.
  • [25]Lucas D, Bruns I, Battista M, Mendez-Ferrer S, Magnon C, Kunisaki Y, Frenette PS: Norepinephrine reuptake inhibition promotes mobilization in mice: potential impact to rescue low stem cell yields. Blood 2012, 119:3962-3965.
  文献评价指标  
  下载次数:39次 浏览次数:7次